Graham Nicholls of Almac Group to Speak on Adaptive Trial Designs and Clinical Supplies at CTS Europe Conference
Product News Feb 16, 2011
The Almac Group has announced that Graham Nicholls, Director of Biostatistics for Almac’s Clinical Technologies business unit, will be speaking at the Clinical Trial Supply Europe conference (CTS Europe) held in Barcelona, Spain, 22-23 February 2011. The conference will be attended by two of Almac’s business units directly involved with providing an integrated clinical supply chain solution involving IXRS® technology, planning, forecasting, packaging, labeling, analytical testing, inventory management, and global distribution of supplies for clinical trials.
Graham Nicholls plans to speak on the topic of the challenges of conducting adaptive trials. A notable expert on this subject, Mr. Nicholls will provide an overview of adaptive trial designs and comment on some of the current regulatory and logistical perspectives of implementing such trials on a global basis.
Additionally, Mr. Nicholls will address some of the particular challenges that adaptive trial designs have on clinical supplies planning, as well as on manufacturing, packaging, and IXRS® technology considerations.
Jim Murphy, President of Almac’s Clinical Technologies Business unit comments on the unique full service clinical supply solution offered by Almac: “Graham’s knowledge of dynamic randomization strategies has helped Almac solidify its reputation as an industry leader in adaptive and other complex trial designs. Graham’s knowledge complements Almac’s logistical expertise in managing clinical supply chains on a global basis, providing our clients with a full-service drug supply management solution for adaptive trials that is unmatched in our industry. As we are seeing an increasing number of adaptive trials, it is important to share Graham’s extensive knowledge at conferences, such as CTS Europe, to help sponsors plan and execute on complex study designs.”